Celiac sprue and malignancies: Analysis of risks and prevention strategies;Einheimische sprue und malignomrisiko

Medizinische Klinik

Volumn 103, Issue 8, 2008, Pages 561-568

  Allgayer, Hubert ^a   Dietrich, Christoph F ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Innere Medizin 2 ^*  (Germany)

Author keywords

Celiac disease; Chronic inflammation; Enteropathy associated malignancies; Prevention strategies; Refractory disease type I type II; T cell, B cell lymphoma; Ultrasound

Indexed keywords

ANAMNESIS; B CELL LYMPHOMA; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CELIAC DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; COLON CANCER; DIAGNOSTIC IMAGING; DISEASE COURSE; EARLY DIAGNOSIS; EVIDENCE BASED PRACTICE; HUMAN; INFLAMMATION; PATIENT ASSESSMENT; PATIENT MONITORING; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; T CELL LYMPHOMA;

ADULT; CASE-CONTROL STUDIES; CELIAC DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; LYMPHOMA; MALE; NEOPLASMS; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 52649093753     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-008-1091-2     Document Type: Review

References (78)

1. Farell RJ, Kely CP. Celiac sprue. N Engl J Med 2002;46:180-8.
2. Trier JS. Diagnosis of celiac sprue. Gastroenterology 1998;115:211-6.
3. Solid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2:647-55.
4. Nuti R, Martini G, Valenti R, et al. Prevalence of undiagnosed celiac syndrome in osteoporotic women. J Intern Med 2001;250:361-6.
5. Stenson WF, Newberry R, Lorenz R, et al. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005;165:393-9.
6. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131: 1981-2002.
7. Hallert C, Grännö C, Hulten S, et al. Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol 2002;37:39-42.
8. Green PH, Jabri B. Celiac disease and other precursors to small-bowel malignancy. Gastroenterol Clin North Am 2002;31:625-39.
9. Holmes GK. Coeliac disease and malignancy. Dig Liver Dis 2002;34:229-37.
10. Leffler D, Saha S, Farell RJ. Celiac disease. Am J Manag Care 2003;9:825-31.
11. Howdle PD, Jalal PK, Holmes GK, et al. Primary small-bowel malignancy in the UK and its association with celiac disease. Month J Assoc Phys 2003;96: 345-53.
12. Fischbach W. Gastrointestinale Lymphome. Z Gastroenterol 2004;42:1067-72.
13. Gough KR, Read AE, Naish JM. Intestinal reticulosis as a complication of idiopathic steatorrhea. Gut 1962;3:232-9.
14. Harris OD, Cooke WT, Thompson H, et al. Malignancy in adult celiac disease and idiopathic steatorrhea. Am J Med 1967;42:899-912.
15. Holmes GK, Stokes PL, Sorahan TM, et al. Coeliac disease, gluten-free diet and malignancy. Gut 1976;17:612-9.
16. Isaacson P, Wright DH. Intestinal lymphoma associated with malabsorption. Lancet 1978;1:67-70.
17. Selby WS, Gallagher ND. Malignancy in a 19-year experience of adult celiac disease. Dig Dis Sci 1979;24:684-8.
18. Cooper BT, Holmes GK, Cooke WT. Lymphoma risk in celiac disease of later life. Digestion 1982;23:89-92.
19. Freeman HJ, Chiu BK. Multifocal small bowel lymphoma and latent celiac sprue. Gastroenterology 1986;90:1992-7.
20. Grün M, Schulz A Kraus J, et al. Ileussymptomatik durch drei unterschiedlich differenzierte Dünndarmkarzinome bei einheimischer Sprue. Dtsch Med Wochenschr1989;114:709-11.
21. Loughran TP Jr, Kadin ME, Deeg HJ. T-cell intestinal lymphoma associated with celiac sprue. Ann Intern Med 1986;104:44-7.
22. Nielsen SN, Wold LE. Adenocarcinoma of jejunum in association with nontropical sprue. Arch Pathol Lab Med 1986;110:822-4.
23. Ormann W, Hirschmann WD, Alexandrakis E, et al. T-Zell-Lymphom und Sprue. Dtsch Med Wochenschr 1989;114:1324-7.
24. Roehrkasse RL, Roberts IM, Wald A, et al. Celiac sprue complicated by lymphoma presenting with multiple gastric ulcers. Gastroenterology 1986;91:740-5.
25. Swinson CM, Slavin G, Coles EC, et al. Coeliac disease and malignany. Lancet 1983;1:111-5.
26. Holmes GK, Prior P, Lane MR, et al. Malignancy in celiac disease - effect of a gluten free diet. Gut 1989;30:333-8.
27. Corazza GR, Biagi F, Volta U, et al. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997;350:106-9.
28. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002;287:1413-9.
29. Green PH, Fleischhauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med 2003;115:191-5.
30. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed celiac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004;20:769-75.
31. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with celiac disease: population-based cohort study. Br Med J 2004;329: 716-9.
32. Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphoma in celiac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005;54:54-9.
33. Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: a 30-year population-based study. Dig Liver Dis 2006;38:374-80.
34. Silano M, Volta U, Vincenzi AD, et al. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 2008;53:972-6.
35. Anderson LA, McMillan SA, Watson RG, et al. Malignancy and mortality in a population-based cohort of patients with celiac disease or "quot;gluten sensitivity". World J Gastroenterol 2007;13:146-51.
36. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with celiac disease and their relatives: a cohort study. Lancet 2001;358:356-61.
37. Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002;123:1428-35.
38. Peters U, Askling G, Gridley G, et al. Causes of death in patients with celiac disease in a population based Swedish cohort. Arch Intern Med 2003; 163:1566-72.
39. Rothman KJ. Epidemiology. An Introduction. New York: Oxford University Press, 2002.
40. Michaelis J. Epidemiologie - Wissenschaft für die Praxis. Dtsch Ärztebl 1990;87:C1741-6.
41. Allgayer H, Holtmeier W, Dietrich CF. Morbus Crohn und Malignomrisiko: Häufigkeit, klinische Charakteristika und mögliche Präventionsstrategien. Med Klin 2007;102:727-33.
42. Lang-Muritano M, Molinari L, Dommann-Scherrer C, et al. Incidence of enteropathy-associated T-cell lymphoma in celiac disease: implications for children and adolescents with type 1 diabetes. Pediatr Diabetes 2002;3:42-5.
43. Schmiegel W, Pox C, Kroesen A. Karzinomprophylaxe. Z Gastroenterol 2004;42:1014-8.
44. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US multi-society task force on colorectal cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85.
45. Liebermann DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-85.
46. Imperiale TF. Towards risk stratification for screening and surveillance of colorectal neoplasma: one small step for the colonoscopist [Editorial]. Gastroenterology 2007;133:1364-6.
47. Trier J, Falchuk Z, Carey M, et al. Celiac sprue and refractory sprue. Gastroenterology 1978;75:307-16.
48. O'Mahony S, Howdle P, Losowsky M. Review article: Management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996;1: 671-8.
49. Longstreth G. Sucessful treatment of refractory sprue with cyclosporine. Ann Intern Med 1993;119: 1014-6.
50. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000;119:243-51.
51. Mulder CJ, Wahab PJ, Moshaver B, et al. Refractory celiac disease: a window between celiac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol Suppl 2000;232:32-7.
52. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease and enteropathy-associated T-cell lymphoma. Lancet 2000;356:203-8.
53. Olaussen RW, Lovik A, Tollefsen S, et al. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol 2005;3:875-85.
54. De Patey-Mariaud SN, Celleir C, Jabri B, et al. Distinction between celiac disease and refractory sprue: a simple immunohistochemical method. Histopathology 2000;37:70-7.
55. Bagdi E, Diss TC, Munson P, et al. Mucosal intraepithelial lymphocytes in enteropathy-associated lymphoma, ulcerative jejunitis and refractory celiac disease constitute a neoplastic population. Blood 1999;94:260-4.
56. Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998;114:471-81.
57. Blumberg R, Yokey C, Gross G, et al. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V?̂ T cell receptor genes. J Immunol 1993;150:5144-53.
58. Ashton-Key M, Diss T, Pan L, et al. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997;151:493-8.
59. Wright D, Jones D, Clark H, et al. Is adult-onset celiac disease due to a low-grade lymphoma of intraepithelial T lymphocytes? Lancet 1991;337: 1373-4.
60. Menton JJ, Ben Ahmed M, Begue B, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphangenesis in celiac disease. Gastroenterology 2003;125:730-45.
61. Forsberg G, Hernell O, Melgar S, et al. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002;123:667-78.
62. Di Sabatino A, Cicccioppo R, Cupell F, et al. Epithelium derived interleukin 15 regulated intraepithelial lymphocyte Th1 cytokine production, cytotoxicity and survival in celiac disease. Gut 2006; 55:469-77.
63. Brosterhus H, Brings S, Leyendecker H, et al. Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion. Eur J Immunol 1999;29:4053-9.
64. Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, celiac disease and enteropathy-associated T-cell lymphoma. Scand J Gastroenterol 2000; 35:785-90.
65. Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002;118:459-63.
66. Abdulkarim AS, Burgart LJ, See J, et al. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002;97:2016-21.
67. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2006;129: 1294-301.
68. Wolters VM, Wieke HM, Verbeck M, et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol 2007;5:1399-405.
69. Murray JA, Moore S, Van Dyke CT, et al. HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol 2007;5:1406-13.
70. Gilett HR, Arnott ID, McIntyre M, et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002;122: 800-5.
71. Vivas S, Ruiz de Morales JM, Ramos F, et al. Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma [Letter]. N Engl J Med 2006;354:2514-5.
72. Holtmeier W. Diagnostik der Zöliakie/Sprue. Z Gastroenterol 2005;43:1243-52.
73. Krauss N, Schuppan D. Monitoring nonresponsive patients who have celiac disease. Gastrointest Endosc Clin N Am 2006;16:317-27.
74. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin-lymphoma by subtype. J Natl Cancer Inst 2006;98:51-60.
75. Dietrich CF, Brunner V, Seifert H, et al. Intestinale B-Bild-Sonographie bei Patienten mit einheimischer Sprue. Ultraschall Med 1999;20:242-7.
76. Hollerweger A, Dietrich CF. "White bowel - die weiße Darmwand". Sonographischer Ausdruck einer mesenterialen Lymphstauung? Ultraschall Med 2005;26:127-33.
77. Hollerweger A, Macheiner P, Dirks K, et al. Ausgeprägtes echoarmes Darmwandödem im Ultraschall: ähnliches Erscheinungsbild bei verschiedenen Erkrankungen. Ultraschall Med 2006;27:234-9.
78. Dietrich CF, Zeuzem S, Caspary WF, et al. Sonographische Lymphknotendarstellung im Abdomen bei gesunden Probanden. Ultraschall Med 1998; 19:265-9.